Linical Co., Ltd. (2183.T) JPX

Currency In JPY

AD

Linical Co., Ltd.

Address

Shin-Osaka Brick Building

Osaka, OS 532-0003

Japan

Phone

81 6 6150 2478

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

577

First IPO Date

October 27, 2008

Key Executives

NameTitlePayYear Born
Kazuhiro HatanoPresident, Chief Executive Officer, Chief Strategy Officer, Chief Commercial Officer & Representative Director01965
Shiori YamaguchiExecutive Officer & CCO01975
Akihiro TakahashiExecutive Officer & CFO01967
Jun KawaiExecutive Officer, Chief Clinical Operation Officer & Chief Administrative Officer01968
Satoru ToyotaExecutive Officer & Head of Oncology Business Unit (HQ, Japan)0N/A
Tomoko InomataExecutive Officer & Head of Primary Business Unit (HQ, Japan)0N/A
Tracy GoekenChief Medical Officer0N/A
Toshiaki NagafujiExecutive Officer, Chief Technology Officer & Head of Innovative Drug Development Business Unit (HQ, Japan)0N/A
Tokuno MasayoshiExecutive Officer & Chief Information Officer0N/A
Keigo TsujimotoExecutive Officer & Chief Project Officer01964
Clareece WestPresident & Chief Commercial Officer of Americas & Europe0N/A
Masaya MiyazakiExecutive Officer, APAC-Chief Commercial Officer & Chief Asia Pacific Officer01971
AD

Description

Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

AD